The Contracting Authority intends to establish a single-party Framework Agreement with a suitably qualified economic operator for the supply of Infliximab pharmaceutical products and related services. While this competition is being conducted by Beaumont Hospital, the following organisations shall have the right to award contracts under this framework agreement by reference to the terms contained in the Framework Agreement entered into between Beaumont Hospital and the successful tenderer: โ Connolly Hospital Blanchardstown, โ Cavan and Monaghan Hospital, โ Our Lady of Lourdes Hospital, โ Louth County Hospital. No guarantee is offered regarding the quantity or scope of any such contracts. Moreover, any contract entered into between any party listed above and the successful framework member shall operate independently to any contract in force between Beaumont Hospital and the successful framework member and shall be managed locally by the relevant party.
Deadline
The time limit for receipt of tenders was 2018-11-09.
The procurement was published on 2018-10-24.
Suppliers
The following suppliers are mentioned in award decisions or other procurement documents:
Contract notice (2018-10-24) Object Scope of the procurement
Title: Pharmaceutical products
Reference number: 2667
Short description:
The Contracting Authority intends to establish a single-party Framework Agreement with a suitably qualified economic operator for the supply of Infliximab pharmaceutical products and related services. While this competition is being conducted by Beaumont Hospital, the following organisations shall have the right to award contracts under this framework agreement by reference to the terms contained in the Framework Agreement entered into between Beaumont Hospital and the successful tenderer:
โ Connolly Hospital Blanchardstown,
โ Cavan and Monaghan Hospital,
โ Our Lady of Lourdes Hospital,
โ Louth County Hospital.
No guarantee is offered regarding the quantity or scope of any such contracts. Moreover, any contract entered into between any party listed above and the successful framework member shall operate independently to any contract in force between Beaumont Hospital and the successful framework member and shall be managed locally by the relevant party.
The Contracting Authority intends to establish a single-party Framework Agreement with a suitably qualified economic operator for the supply of Infliximab pharmaceutical products and related services. While this competition is being conducted by Beaumont Hospital, the following organisations shall have the right to award contracts under this framework agreement by reference to the terms contained in the Framework Agreement entered into between Beaumont Hospital and the successful tenderer:
โ Connolly Hospital Blanchardstown,
โ Cavan and Monaghan Hospital,
โ Our Lady of Lourdes Hospital,
โ Louth County Hospital.
No guarantee is offered regarding the quantity or scope of any such contracts. Moreover, any contract entered into between any party listed above and the successful framework member shall operate independently to any contract in force between Beaumont Hospital and the successful framework member and shall be managed locally by the relevant party.
Notice metadata
Original language: English ๐ฃ๏ธ
Document type: Contract notice
Nature of contract: Supplies
Regulation: European Union, with participation of GPA countries
Common procurement vocabulary (CPV)
Code: Pharmaceutical products๐ฆ
Additional CPV: Pharmaceutical products๐ฆ Place of performance
NUTS region: Dublin
๐๏ธ
Procedure
Procedure type: Open procedure
Type of bid: Submission for all lots
Award criteria
The most economic tender
Please consult the Invitation to Tender document, available to download from www.etenders.gov.ie
Object Scope of the procurement
Short description:
The Contracting Authority intends to establish a single-party Framework Agreement with a suitably qualified economic operator for the supply of Infliximab pharmaceutical products and related services. While this competition is being conducted by Beaumont Hospital, the following organisations shall have the right to award contracts under this framework agreement by reference to the terms contained in the Framework Agreement entered into between Beaumont Hospital and the successful tenderer:
The Contracting Authority intends to establish a single-party Framework Agreement with a suitably qualified economic operator for the supply of Infliximab pharmaceutical products and related services. While this competition is being conducted by Beaumont Hospital, the following organisations shall have the right to award contracts under this framework agreement by reference to the terms contained in the Framework Agreement entered into between Beaumont Hospital and the successful tenderer:
โ Connolly Hospital Blanchardstown,
โ Cavan and Monaghan Hospital,
โ Our Lady of Lourdes Hospital,
โ Louth County Hospital.
No guarantee is offered regarding the quantity or scope of any such contracts. Moreover, any contract entered into between any party listed above and the successful framework member shall operate independently to any contract in force between Beaumont Hospital and the successful framework member and shall be managed locally by the relevant party.
No guarantee is offered regarding the quantity or scope of any such contracts. Moreover, any contract entered into between any party listed above and the successful framework member shall operate independently to any contract in force between Beaumont Hospital and the successful framework member and shall be managed locally by the relevant party.
Estimated total value: 20 000 000 EUR ๐ฐ
Short description:
The Contracting Authority intends to establish a single-party Framework Agreement with a suitably qualified economic operator for the supply of Infliximab pharmaceutical products and related services, as more fully described in the associated Invitation to Tender document. The scope of this Framework Agreement comprises the supply of Infliximab pharmaceutical products, the supply of any other formulation of chimeric monoclonal antibody biologic drug in any dose, strength or quantity and the provision of related services, including support and educational initiatives.
The Contracting Authority intends to establish a single-party Framework Agreement with a suitably qualified economic operator for the supply of Infliximab pharmaceutical products and related services, as more fully described in the associated Invitation to Tender document. The scope of this Framework Agreement comprises the supply of Infliximab pharmaceutical products, the supply of any other formulation of chimeric monoclonal antibody biologic drug in any dose, strength or quantity and the provision of related services, including support and educational initiatives.
While this competition is being conducted by Beaumont Hospital, and while this framework agreement shall be primarily utilised by Beaumont Hospital, the following organisations shall have the right to award contracts under this Framework Agreement by reference to the terms contained in the Framework Agreement entered into between Beaumont Hospital and the successful tenderer:
While this competition is being conducted by Beaumont Hospital, and while this framework agreement shall be primarily utilised by Beaumont Hospital, the following organisations shall have the right to award contracts under this Framework Agreement by reference to the terms contained in the Framework Agreement entered into between Beaumont Hospital and the successful tenderer:
โ Monaghan Hospital,
No guarantee is offered, nor should any such guarantee be inferred, regarding the quantity or scope of any such contracts. Moreover, any contract entered into between any party listed above and the successful framework member shall operate independently to any contract in force between Beaumont Hospital and the successful framework member and shall be managed locally by the relevant party.
No guarantee is offered, nor should any such guarantee be inferred, regarding the quantity or scope of any such contracts. Moreover, any contract entered into between any party listed above and the successful framework member shall operate independently to any contract in force between Beaumont Hospital and the successful framework member and shall be managed locally by the relevant party.
Estimated value excluding VAT: 20 000 000 EUR ๐ฐ
Duration: 72 months
Description of options:
While this competition is being conducted by Beaumont Hospital, and while this Framework Agreement shall be primarily utilised by Beaumont Hospital, the following organisations shall have the right to award contracts under this Framework Agreement by reference to the terms contained in the Framework Agreement entered into between Beaumont Hospital and the successful tenderer:
While this competition is being conducted by Beaumont Hospital, and while this Framework Agreement shall be primarily utilised by Beaumont Hospital, the following organisations shall have the right to award contracts under this Framework Agreement by reference to the terms contained in the Framework Agreement entered into between Beaumont Hospital and the successful tenderer:
โ Connolly Hospital Blanchardstown,
โ Cavan and Monaghan Hospital,
โ Monaghan Hospital,
โ Our Lady of Lourdes Hospital,
โ Louth County Hospital.
Additional information:
Please consult the Invitation to Tender document, available to download from www.etenders.gov.ie
Place of performance
Main site or place of performance: Dublin 9.
Legal, economic, financial and technical information Conditions for participation
Suitability to pursue the professional activity:
As per the Invitation to Tender document, available to download from www.etenders.gov.ie
In accordance with the provisions of Article 27.3 of Directive 2014/24/EU, the Contracting Authority is availing of shortened timescales for the purposes of establishing this Framework Agreement. The utilisation of shortened timescales is justified by reference to the urgent need to secure a reliable supply of these pharmaceutical products, which are intended for use in an acute hospital environment.
In accordance with the provisions of Article 27.3 of Directive 2014/24/EU, the Contracting Authority is availing of shortened timescales for the purposes of establishing this Framework Agreement. The utilisation of shortened timescales is justified by reference to the urgent need to secure a reliable supply of these pharmaceutical products, which are intended for use in an acute hospital environment.
Justification for the framework agreement:
In accordance with Article 33.1 of Directive 2014/24/EU, the maximum potential duration of this framework agreement (i.e., six years) is justified by reference to the considerable implementation activities that will be required in order to successfully introduce the products in question to the Contracting Authorityโs care pathways.
In accordance with Article 33.1 of Directive 2014/24/EU, the maximum potential duration of this framework agreement (i.e., six years) is justified by reference to the considerable implementation activities that will be required in order to successfully introduce the products in question to the Contracting Authorityโs care pathways.
Justification for framework agreement duration over four years:
In accordance with Article 33.1 of Directive 2014/24/EU, the maximum potential duration of this framework agreement (i.e., six years) is justified by reference to the considerable implementation activities that will be required in order to successfully introduce the products in question to the Contracting Authorityโs care pathways.
Justification for framework agreement duration over four years
In accordance with Article 33.1 of Directive 2014/24/EU, the maximum potential duration of this framework agreement (i.e., six years) is justified by reference to the considerable implementation activities that will be required in order to successfully introduce the products in question to the Contracting Authorityโs care pathways.
Time of receipt of tenders: 12:00
Languages in which tenders or requests to participate may be submitted: English ๐ฃ๏ธ
Tender validity period: 12 months
Tender opening date: 2018-11-09 ๐
Tender opening time: 12:00
Place: Tenders shall be opened using the electronic post-box feature of the Irish government's Procurement Opportunities Portal (www.etenders.gov.ie).
Additional information:
Tenders shall be opened electronically by 2 employees of Beaumont Hospital's Procurement Department.
Complementary information Review body
Name: The High Court
Postal address: Central Office of the High Court, The Four Courts
Postal town: Dublin
Postal code: 7
Country: Ireland ๐ฎ๐ช
Phone: +353 18886511๐
E-mail: highcourtcentraloffice@courts.ie๐ง
Internet address: https://www.courts.ie๐
Information about review deadlines:
The Contracting Authority undertakes that this Framework Agreement will not be established until the expiry of a period of fourteen calendar days, commencing on the day after the date of electronic notification of all concerned tenderers. This โstandstill periodโ is being observed in accordance with the provisions of S.I. 130 of 2010.
The Contracting Authority undertakes that this Framework Agreement will not be established until the expiry of a period of fourteen calendar days, commencing on the day after the date of electronic notification of all concerned tenderers. This โstandstill periodโ is being observed in accordance with the provisions of S.I. 130 of 2010.
Source: OJS 2018/S 208-474271 (2018-10-24)
Contract award notice (2019-01-09) Object Scope of the procurement
Short description:
The Contracting Authority intends to establish a single-party Framework Agreement with a suitably qualified economic operator for the supply of Infliximab pharmaceutical products and related services. While this competition is being conducted by Beaumont Hospital, the following organisations shall have the right to award contracts under this Framework Agreement by reference to the terms contained in the Framework Agreement entered into between Beaumont Hospital and the successful tenderer:
โ Connolly Hospital Blanchardstown,
โ Cavan and Monaghan Hospital,
โ Our Lady of Lourdes Hospital,
โ Louth County Hospital.
No guarantee is offered regarding the quantity or scope of any such contracts. Moreover, any contract entered into between any party listed above and the successful framework member shall operate independently to any contract in force between Beaumont Hospital and the successful framework member and shall be managed locally by the relevant party.
The Contracting Authority intends to establish a single-party Framework Agreement with a suitably qualified economic operator for the supply of Infliximab pharmaceutical products and related services. While this competition is being conducted by Beaumont Hospital, the following organisations shall have the right to award contracts under this Framework Agreement by reference to the terms contained in the Framework Agreement entered into between Beaumont Hospital and the successful tenderer:
โ Connolly Hospital Blanchardstown,
โ Cavan and Monaghan Hospital,
โ Our Lady of Lourdes Hospital,
โ Louth County Hospital.
No guarantee is offered regarding the quantity or scope of any such contracts. Moreover, any contract entered into between any party listed above and the successful framework member shall operate independently to any contract in force between Beaumont Hospital and the successful framework member and shall be managed locally by the relevant party.
Total value of the procurement: 20 000 000 EUR ๐ฐ
Notice metadata
Document type: Contract award notice
Procedure
Type of bid: Not applicable
Reference Dates
Date dispatched: 2019-01-09 ๐
Publication date: 2019-01-14 ๐
Identifiers
Notice number: 2019/S 009-016091
Refers to notice: 2018/S 208-474271
OJ-S issue: 9
Additional information
Please consult the Invitation to tender document, available to download from www.etenders.gov.ie
Object Scope of the procurement
Short description:
The Contracting Authority intends to establish a single-party Framework Agreement with a suitably qualified economic operator for the supply of Infliximab pharmaceutical products and relatedโฆ
โฆ services. While this competition is being conducted by Beaumont Hospital, the following organisations shall have the right to award contracts under this Framework Agreement by reference to the terms contained in the Framework Agreement entered into between Beaumont Hospital and the successful tenderer:
โฆ services, as more fully described in the associated invitation to tender document. The scope of this Framework Agreement comprises the supply of Infliximab pharmaceutical products, the supply of any other formulation of chimeric monoclonal antibody biologic drug in any dose, strength or quantity and the provision of related services, including support and educational initiatives.
While this competition is being conducted by Beaumont Hospital, and while this Framework Agreement shall be primarily utilised by Beaumont Hospital, the following organisations shall have the right to award contracts under this Framework Agreement by reference to the terms contained in the Framework Agreement entered into between Beaumont Hospital and the successful tenderer:
While this competition is being conducted by Beaumont Hospital, and while this Framework Agreement shall be primarily utilised by Beaumont Hospital, the following organisations shall have the right to award contracts under this Framework Agreement by reference to the terms contained in the Framework Agreement entered into between Beaumont Hospital and the successful tenderer:
Additional information:
Please consult the Invitation to tender document, available to download from www.etenders.gov.ie
Place of performance
Main site or place of performance: Dublin 9
Award of contract
Date of contract conclusion: 2018-11-19 ๐
Name: Pfizer Healthcare Ireland
National registration number: ie4859668n
Postal address: 9 Riverwalk, National Digital Park
Postal town: Dublin 22
Postal code: Citywest
Country: Ireland ๐ฎ๐ช
Phone: +353 0867719619๐
E-mail: padraig.cahill@pfizer.com๐ง
Country: Dublin
๐๏ธ
Internet address: http://www.pfizer.com๐
Total value of the procurement: 16 000 000 EUR ๐ฐ
Information about tenders
Number of tenders received: 3
Reference Additional information
Please consult the invitation to tender document, available to download from www.etenders.gov.ie